SEC Form 4 · accession 0001209191-18-009398
Travere Therapeutics, Inc. · TVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil F. McFarlane
Officer — Chief Operating Officer
Period of report
Feb 8, 2018
Accepted (ET)
Feb 12, 2018 · 8:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 8, 2018 | A | 2,546 | $0.00 | A | 17,448 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,280 ordinary shares of the Issuer acquired by the reporting person on November 30, 2017 pursuant to an employee stock purchase program.